Cancer Genetics & Molecular Oncology
Clinician referral requiredDPYD Mutations (5 Variants)
Tests five DPYD variants linked to the risk of severe side effects from fluoropyrimidine chemotherapy.
Test code:
Sample
Blood
Method
Sanger sequencing
Turnaround
5 days
About this test
Tests five DPYD variants linked to the risk of severe side effects from fluoropyrimidine chemotherapy.
Yes, a doctor's referral is required for this test.
No special preparation is usually required; confirm specimen-specific instructions with the laboratory.
Samples can be collected at the GeneLabs X Centre in Kotte or at any of our designated sample collection centres.
The result reports the five DPYD variants included in this assay and their potential relevance to fluoropyrimidine toxicity risk. A negative result does not exclude all DPYD-related risk; treatment decisions require clinical assessment.
Need help?
Not sure this is the right test?
Our team can help you or your clinician find the right pathway.
